Pure Global
NCT06063876

Experimental Peri-implant Mucositis on Implant Sites That Were Previously Treated With or Without Implantoplasty

Progression and Resolution of Experimental Peri-implant Mucositis on Now Healthy Implant Sites That Were Previously Treated With or Without Implantoplasty: A Controlled Clinical Trial
University of Pittsburgh·ClinicalTrials.gov·procedureEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Peri-implant Mucositis,Peri-Implantitis
Drug/Device/Intervention
Induction of experimental peri-implant mucositis
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
University of Pittsburgh
Location
Pittsburgh, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 05, 2023
End date
Dec 01, 2025
Enrollment
30 participants
Primary outcome

Changes in the modified Gingival Index (mGI) between 21 and 42 days

Summary

This controlled clinical trial will assess clinically, immunologically, and microbiologically
 the healing of experimental peri-implant mucositis (PIM) lesions in implants treated
 previously with implantoplasty (IP) compared to those treated without IP.

ICD-10 classifications
Oral mucositis (ulcerative)Infection and inflammatory reaction due to other internal orthopaedic prosthetic devices, implants and graftsInfection and inflammatory reaction due to prosthetic device, implant and graft in genital tractInfection and inflammatory reaction due to other internal prosthetic devices, implants and graftsPeritonitis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06063876
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06063876 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Pittsburgh and is currently Enrolling by invitation. The study focuses on Peri-implant Mucositis,Peri-Implantitis. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.